Rallybio Corporation (RLYB) vs Tonix Pharmaceuticals Holding Corp. (TNXP)
- Rallybio Corporation RLYB 15.74 −1.01%
- Tonix Pharmaceuticals Holding Corp. TNXP 4.63 −9.39%
Rallybio Corporation and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Rallybio Corporation and Tonix Pharmaceuticals Holding Corp. are of similar size ($87.6M and $85.6M). Tonix Pharmaceuticals Holding Corp. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 3.3×. Tonix Pharmaceuticals Holding Corp. grew revenue faster over the last twelve months: 196.0% against 1.18%. Rallybio Corporation has the higher net margin (0.00% vs −548.6%) and the lower return on invested capital (−944.4% vs −224.5%). Across the 17 metrics below, Rallybio Corporation leads on 11 and Tonix Pharmaceuticals Holding Corp. on 6.
Valuation
Profitability
| Metric | RLYB | TNXP | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 83.83% | 65.16% |
| Operating margin | 0.00% | (568.43%) | 0.00% |
| Net margin | 0.00% | (548.64%) | 0.00% |
| Free cash flow margin | 0.00% | (543.29%) | 0.00% |
| Return on equity | 34.52% | (81.82%) | (50.12%) |
| Return on assets | 32.85% | (72.34%) | (45.60%) |
| Return on invested capital | (944.36%) | (224.52%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack